Macrophages from peripheral blood of leprosy patients, both multi-bacillary and paucibacillary are unable to kill phagocytosed Mycobacterium leprae due to their inability to produce superoxide (07) and hydroxyl radicals (OH ). The macrophages from healthy individuals are able to kill M. keprae along with release of 07 and OH -radicals. The deficiency in the macrophages of both types of leprosy patients is removed by activation of these cells when exposed to a culture supernatant obtained after stimulation of peripheral blood mononuclear cells from the same patients with delipidified cell components of M. leprae which are most likely cell wall proteins. The activation of macrophages also leads to recognition ofwhole live M. leprae as an antigen by cells from lepromatous patients. This activation of the phagocytes by delipidified cell components is blocked by cyclosporin A, indicating the possible role of several steps involved in immune activation of cells. The observations thus indicate the significant ability of delipidified cell components to eliminate the deficiencies in the macrophages from leprosy patients and restore them to behave like the cells from healthy individuals. Considering all these, it is suggested that delipidified cell components could be potential modulators, and are probably capable of functioning as a vaccine for leprosy.
INTRODUCTION
The importance of cell-mediated immunity in resistance to infection caused by intracellular pathogens has been well established. Mononuclear phagocytes clearly play primary roles in the efferent limb of cellular control of such infections. The microbicidal ability of phagocytes through reactive oxygen intermediates (ROI) like hydrogen peroxide (H202), superoxide (02) and hydroxyl radicals (OH-) is also a basic defence mechanism of the human body against microbial infections (Babior, Curnutte & Kipnes, 1975; Nathan et al., 1979; Klebanoff, 1982) .
Mycobacteria like M. bovis BCG (Ando et al., 1979) , M. microti (Walker & Lowrie, 1981) , M. tuberculosis (Jackett, Aber & Lowrie, 1978) and M. intracellulare (Gangadharam & Pratt, 1984) as well as M. leprae (Klebanoff & Shepard, 1984; Sharp, Colston & Banerjee, 1985) have been shown to be susceptible to killing by H202. There are reports that claim an inability of the phagocytes from healthy individuals to release 02 on stimulation with M. leprae (Holzer et al. 1986 ), yet others have reported Correspondence: Dr P. R. Mahadevan, Director, Experimental Biology and Therapy, The foundation for medical research, 84-A, R. G. Thadani Marg, Worli, Bombay 400 018, India. that H202 and 02 are produced by macrophages of leprosy patients in response to agents such as phorbol myristate acetate (PMA) (Sharp& Banerjee, 1985) . Nevertheless, a recent report (Holzer et al., 1988) indicated that M. leprae are able to induce low but significant levels of 07 in the macrophages of healthy individuals and phagocytose the bacteria slowly.
Recently, we have reported that along with an ability to produce 0°and H202, phagocytes from healthy individuals are able to kill M. leprae, unlike from lepromatous leprosy patients (Marolia & Mahadevan, 1987 , 1988 . The inability of M. leprae to be killed by macrophages from lepromatous leprosy patients was then found to be due to lack of 07 production. Further observations made in our laboratory (Desai, Birdi & Antia, 1989) have also confirmed M. leprae being killed by macrophages from healthy individuals. These experiments were independently carried out in connection with the role of interferon-gamma (IFN-y) . As well as recognizing ROI like H202, 02 and OH as basic defence mechanism, the role of IFN-y to stimulate macrophages to produce ROI on challenge with infection of mycobacteria is also substantiated (Nathan et al., 1979; Nogueria et al., 1983; Kaplan & Cohn, 1985) .
We have been successful in isolating and identifying a component of M. keprae, the delipidified portion of the insoluble cell components of M. leprae (DCC) as an immunomodulating agent. The potentialities of DCC which was obtained as an insoluble complex have been reported in detail (Vermani & Mahadevan, 1986; Robinson & Mahadevan, 1987 
MATERIALS AND METHODS

Patient
Leprosy patients reporting at the Acworth Leprosy Hospital, Bombay, formed the major part of the study. The patients were classified on the basis of the Ridley & Jopling (1966) system. The lepromatous group was of the long-term treated (>4 years) bacillary-negative type (B -LL). They were identified as bacteriologically negative, when bacilli were undetectable at multiple skin sites and in the nose, and having had a record of regular treatment in the clinic. The second group is the bacteriologically positive lepromatous type untreated or undergoing treatment (B+LL). The other group of patients were paucibacillary, classified under the group of BT, BB.
The healthy subjects were volunteers living in the same environment, who may have had varied exposure to M. leprae in the city of Bombay. These healthy individuals were not close contacts and had no regular closeness with leprosy patients.
M. leprae were obtained from infected tissues such as spleen and liver from infected armadillo, kindly provided by Dr E. Storrs, Florida, USA. The tissues were collected under aseptic conditions and transported under dry ice to Bombay within a period of 1 week. The tissues were stored at -90'C and pieces were taken out as needed.
For obtaining host tissue-free M. leprae suspension, the infected pieces were repeatedly rinsed in sterile normal saline, to elute the bacilli. The suspension was centrifuged first at 500 g for 10 min to remove any larger debris and later the supernatant was centrifuged at 4500 g for 30 min. This procedure sedimented the acid-fast stainable bacteria. The bacterial suspension showed no catalase activity and was thus considered as free from tissues contaminants. Catalase is a component of host tissue and not produced by M. leprae.
Macrophage culture from the peripheral blood was prepared as reported earlier (Marolia & Mahadevan, 1989) .
H202 was estimated following the method of Pick & Keisari (1980) and adopted to mature macrophage cultures. The method has been described earlier in detail (Marolia & Mahadevan, 1988) . 02 was estimated by the method of Sugimoto et al. (1982) as detailed previously (Marolia & Mahadevan, 1987 Viability of M. leprae inside the macrophages was determined using fluorescein diacetate (FDA) staining method described earlier Bhagaria & Mahadevan, 1987; Marolia & Mahadevan, 1989) , a modification of that described by Kvach, Mungia & Strand (1984 Robinson & Mahadevan (1987) and used from the stock suspension available in the laboratory. Basically, it was the insoluble residue obtained after prolonged sonication of M. leprae and delipidified repeatedly to remove the wall-associated lipids. It was prepared as follows: M. leprae were separated from infected armadillo tissues, washed with saline twice, and 10'°-10" cells/5 ml suspension of the bacilli were prepared in saline. The cells were sonicated in a soniprep (MSE) ultrasonicator at 40C with 5-min pulse followed by 5-min rest for 5 h at a power of 55 W using a 9-5-mm probe. The sonicate was subjected to differential centrifugation as described by Rastogi & David (1981) , with modifications. The crude cell wall was then delipidified by extraction with Cl: M (2: 1) (three times) for 15 min at room temperature (Folch, Lees & Stanley, 1957) (DCC-I). This fraction was further delipidified by extraction with acetone (three times) and ethanol: ether (1: 1) three times for 15 min at room temperature (Robinson & Mahadevan, 1987 Lymphocyte proliferation assay Blood collected under sterile conditions from the subjects was used to prepare mononuclear cells. These cells were separated by centrifuging the blood over Ficol-Triosil (Lymphoprep) gradient. Lymphocyte proliferation using 3H-thymidine (specific activity 9-8 pCi/mmole) was performed as previously reported (Robinson & Mahadevan, 1987 The viability of M. leprae after phagocytosis by the cells of all types of leprosy patients was as good as the viability of bacilli used for the experiment with the cells from such leprosy patients (smear preparation, 48-55%, compared with 50 5-62% after phagocytosis).
The results presented in Table 2 indicate that in the presence of DCC-stimulated culture supernatant the macrophages from all three groups ofpatients could get stimulated to release 07-. In the case of healthy individuals the culture supernatant could only further enhance the production of 02, which was already induced in any case by live M. leprae itself. Thus it was observed that when the supernatant of culture fluid in which the deficient cells from patients were exposed to DCC was added to the same patient's phagocytes, the cells responded well to live M. leprae by producing 027
It was also demonstrable ( (Marolia & Mahadevan, 1987 , 1988 ) and the results of others (Desai et al., 1989) (Marolia & Mahadevan, 1987 , 1988 (Marolia & Mahadevan, 1987 , 1988 (Palay et al., 1986; Varey, Champion & Cooke 1986 ). From our observations it can be assumed that DCC could be presented as antigen, and that following lymphocyte activation there could be release of useful lymphokines. Recent observations of Robinson & Mahadevan (personal communication) have confirmed this assumption.
Thus, our very early observation regarding the importance of delipidified cell wall (Khandke, Salgame & Mahadevan, 1984) and other reported data (Vermani &  Robinson as well as the recently reported results of Kaplan et al. (1988) indicating a role for cell wall proteins as good T cell activating antigens, all point to the importance of delipidified cell wall components.
It seemed that the in vitro stimulation by the complex insoluble antigen from M. leprae (probably as a subunit) endowed a status to the immune-deficient cells of both paucibacillary and multi-bacillary leprosy patients to behave as cells from healthy individuals. Such a modification leads to recognition of live M. leprae, followed by phagocytosis and killing. It may be suggested that this could be the mechanism to induce modulation by any vaccine to be effective in both types of leprosy. If this is so, the DCC has a definite potential for testing as a vaccine in humans. In experiments with mice vaccinated with DCC, activation of the peritoneal macrophages to kill M. keprae through increased ROI was observed. Such a mechanism was absent in non-immunized mice (unpublished data). Taken together, these observations and those of our earlier reports
